Covaxin Phase III trials: Indian vaccine is 77.8% efficient
Bharath Biotech's covaxin was said to be 81 percent effective against coronavirus infections. However, reports from the third phase of ...
Read moreDetailsHome / COVAXIN
Bharath Biotech's covaxin was said to be 81 percent effective against coronavirus infections. However, reports from the third phase of ...
Read moreDetailsEvery US citizen over 18 years of age will be eligible to get vaccinated for coronavirus from 1st May 2021. ...
Read moreDetailsBreezyScroll is a global content platform that provides a unique experience of enhancing the knowledge quotient for its audience by providing the latest news and updates from various categories such as politics, sports, entertainment, technology, and more.
The platform aims to provide a concise and easy-to-read format for its users. BreezyScroll covers news stories from around the world, majorly the United States. The platform was launched in 2021 and has become one of the fastest-growing content companies in the US.
© 2024 · BreezyScroll.com